International Clinical Trials in Pediatrics/Neonatology

Belgium

• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  Aalst; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  Bruxelles; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  Edegem; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  Leuven; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Aalst; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Bruxelles; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Leuven; Research Site:
  
  

Bulgaria

• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Plovdiv; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Sofia; Research Site:
  
  

Canada

• Crohn's Disease (Pediatric): Would you be interested in participating in a pediatric clinical research trial with treatment for Pediatric Crohn’s Disease?
  Ottawa, Ontario; Research Site
  
  
• Hypertension (High Blood Pressure - Pediatric): A study of oral sildenafil in the treatment of children with Pulmonary Arterial Hypertension. Study Title: A Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Parallel Group Study of Oral Sildenafil in the Treatment of Children, Aged 1-17 Years, With Pulmonary Arterial Hypertension.
  Vancouver; British Columbia Children's Hospital
  
  
• Hypertension (High Blood Pressure - Pediatric): A study of oral sildenafil in the treatment of children with Pulmonary Arterial Hypertension. Study Title: A Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Parallel Group Study of Oral Sildenafil in the Treatment of Children, Aged 1-17 Years, With Pulmonary Arterial Hypertension.
  Edmonton; University of Alberta, Walter Mackenzie Health Sciences Centre
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.
  Coquitlam, BC; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Saskatoon, SK; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Winnipeg, MB; Research Site:
  
  

Czech Republic

• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Brno; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Plzen; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Praha; Research Site:
  
  

Denmark

• Influenza: A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.
  Aalborg; Research Site:
  
  

Estonia

• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  Tallinn; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  Tartu; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Tallinn; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Tartu; Research Site:
  
  

France

• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  Paris; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  Toulouse; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  Tours; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Paris; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Toulouse; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Tours; Research Site:
  
  

Germany

• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  Aachen; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  Heidelberg; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  München; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Aachen; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Berlin; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Essen; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Hamburg; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Heidelberg; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  München; Research Site:
  
  

Greece

• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Athens; Research Site:
  
  

Hungary

• Hypertension (High Blood Pressure - Pediatric): A study of oral sildenafil in the treatment of children with Pulmonary Arterial Hypertension. Study Title: A Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Parallel Group Study of Oral Sildenafil in the Treatment of Children, Aged 1-17 Years, With Pulmonary Arterial Hypertension.
  Szeged; University of Szeged, AOK Department of Pediatrics
  
  
• Hypertension (High Blood Pressure - Pediatric): A study of oral sildenafil in the treatment of children with Pulmonary Arterial Hypertension. Study Title: A Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Parallel Group Study of Oral Sildenafil in the Treatment of Children, Aged 1-17 Years, With Pulmonary Arterial Hypertension.
  Budapest; Gyorgy Gottsegen National Institute of Cardiology
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  Budapest; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  Pecs; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  Szeged; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Budapest; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Pecs; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Szeged; Research Site:
  
  

India

• Hypertension (High Blood Pressure - Pediatric): A study of oral sildenafil in the treatment of children with Pulmonary Arterial Hypertension. Study Title: A Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Parallel Group Study of Oral Sildenafil in the Treatment of Children, Aged 1-17 Years, With Pulmonary Arterial Hypertension.
  Kochi; Amrita Institute of Medical Sciences & Research Centre, Department of Pediatric Cardiology
  
  
• Hypertension (High Blood Pressure - Pediatric): A study of oral sildenafil in the treatment of children with Pulmonary Arterial Hypertension. Study Title: A Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Parallel Group Study of Oral Sildenafil in the Treatment of Children, Aged 1-17 Years, With Pulmonary Arterial Hypertension.
  Hyderabad; The Institute of Medical Sciences, CARE Hospital
  
  

Israel

• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  Jerusalem; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  Petah Tikva; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  Ramat Gan; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Haifa; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Jerusalem; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Petah Tikva; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Ramat Gan; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Tel Aviv; Research Site:
  
  

Italy

• Hypertension (High Blood Pressure - Pediatric): A study of oral sildenafil in the treatment of children with Pulmonary Arterial Hypertension. Study Title: A Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Parallel Group Study of Oral Sildenafil in the Treatment of Children, Aged 1-17 Years, With Pulmonary Arterial Hypertension.
  Bologna; Policlinico Sant'Orsola
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  Pavia; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Padova; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Pavia; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Roma; Research Site:
  
  

Lithuania

• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  Kaunas; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  Vilnius; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Kaunas; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Vilnius; Research Site:
  
  

Poland

• Hypertension (High Blood Pressure - Pediatric): A study of oral sildenafil in the treatment of children with Pulmonary Arterial Hypertension. Study Title: A Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Parallel Group Study of Oral Sildenafil in the Treatment of Children, Aged 1-17 Years, With Pulmonary Arterial Hypertension.
  Warszawa; Instytut Pomnik Centrum Zdrowia Dziecka, Klinika Kardiologii
  
  
• Hypertension (High Blood Pressure - Pediatric): A study of oral sildenafil in the treatment of children with Pulmonary Arterial Hypertension. Study Title: A Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Parallel Group Study of Oral Sildenafil in the Treatment of Children, Aged 1-17 Years, With Pulmonary Arterial Hypertension.
  Krakow; Uniwersytecki Szpital Dzieciecy w Krakowie, Oddzial Kardiologiczny
  
  
• Hypertension (High Blood Pressure - Pediatric): A study of oral sildenafil in the treatment of children with Pulmonary Arterial Hypertension. Study Title: A Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Parallel Group Study of Oral Sildenafil in the Treatment of Children, Aged 1-17 Years, With Pulmonary Arterial Hypertension.
  Zabrze; Slaskie Centrum Chorob Serca, Oddzial Kliniczny Wrodzonych Wad Serca i Kardiologii Dzieciecej
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Bialystok; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Lodz; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Szczecin; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Warszawa; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Wroclaw; Research Site:
  
  

Romania

• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Bucharest; Research Site:
  
  

Russia

• Hypertension (High Blood Pressure - Pediatric): A study of oral sildenafil in the treatment of children with Pulmonary Arterial Hypertension. Study Title: A Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Parallel Group Study of Oral Sildenafil in the Treatment of Children, Aged 1-17 Years, With Pulmonary Arterial Hypertension.
  Moscow; Bakoulev Scientific Center for Cardiovascular Surgery RAMS
  
  
• Hypertension (High Blood Pressure - Pediatric): A study of oral sildenafil in the treatment of children with Pulmonary Arterial Hypertension. Study Title: A Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Parallel Group Study of Oral Sildenafil in the Treatment of Children, Aged 1-17 Years, With Pulmonary Arterial Hypertension.
  Moscow; Institute of Paediatrics and Paediatric Surgery
  
  

Spain

• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  Madrid; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Barcelona; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Madrid; Research Site:
  
  

Sweden

• Hypertension (High Blood Pressure - Pediatric): A study of oral sildenafil in the treatment of children with Pulmonary Arterial Hypertension. Study Title: A Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Parallel Group Study of Oral Sildenafil in the Treatment of Children, Aged 1-17 Years, With Pulmonary Arterial Hypertension.
  Goteborg; Barnhjartcentrum
  
  
• Hypertension (High Blood Pressure - Pediatric): A study of oral sildenafil in the treatment of children with Pulmonary Arterial Hypertension. Study Title: A Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Parallel Group Study of Oral Sildenafil in the Treatment of Children, Aged 1-17 Years, With Pulmonary Arterial Hypertension.
  Lund; Barn-och Ungdomscentrum
  
  

Switzerland

• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Zürich; Research Site:
  
  

Ukraine

• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Kiev; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Lugnansk; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Zaporozhye; Research Site:
  
  

United Kingdom

• Influenza: A Study of Tamiflu (Oseltamivir) for the Seasonal Prophylaxis of Influenza in Immunocompromised Patients.
  Birmingham; Research Site:
  
  
• Influenza: A Study of Tamiflu (Oseltamivir) for Treatment of Influenza in Immunocompromised Patients.
  Nottingham; Research Site: